Still J G, Greiss F C
Gynecol Invest. 1976;7(4):187-200. doi: 10.1159/000301381.
Changes in the left uterine artery blood flow (YBF) after intraarterial administration of estradiol-17beta and cis- and trans-clomiphene citrate to conscious, oophorectomized ewes were monitored by chronically implanted electromagnetic flow probes. Cis-clomiphene produced UBF increases comparable to or greater than those produced by estradiol-17beta but at dose levels 20 times greater. Comparison of UBF response curves for cis-clomiphene with those for estradiol-17beta showed a delayed onset of initial vasodilation and a delayed peak response. The duration of uterine vasodilation produced by cis-clomiphene was dose-dependent and exceeded that produced by estradiol-17beta. Similar reponses were observed with trans-clomiphene but at dose levels at least 1,000 times those of estradiol-17beta. The characteristics of clomiphene-induced UBF responses that differed from those after estradiol-17beta may reflect differences in estrogen receptor activation between the compounds.
通过长期植入的电磁流量探头,监测向清醒的、已切除卵巢的母羊动脉内注射17β-雌二醇和顺式及反式枸橼酸氯米芬后左子宫动脉血流(YBF)的变化。顺式枸橼酸氯米芬引起的子宫血流量增加与17β-雌二醇相当或更大,但剂量水平是其20倍。顺式枸橼酸氯米芬与17β-雌二醇的子宫血流量反应曲线比较显示,初始血管舒张的开始延迟,峰值反应也延迟。顺式枸橼酸氯米芬引起的子宫血管舒张持续时间呈剂量依赖性,且超过了17β-雌二醇引起的持续时间。反式枸橼酸氯米芬也观察到类似反应,但剂量水平至少是17β-雌二醇的1000倍。氯米芬诱导的子宫血流量反应特征与17β-雌二醇后的不同,可能反映了这两种化合物在雌激素受体激活方面的差异。